Related guidance: NICE Clinical Guideline CG184 (2014): Dyspepsia

Therapeutic AreaFormulary ChoicesCost for 28
(unless otherwise stated)
Rationale for decision / comments
H2 - receptor antagonistsRanitidine150mg tablets: £1.46 (60)
300mg tablets: £1.35 (30)
75mg/5ml S/F oral solution: £6.45 (300ml)
Ranitidine is recommended as first line treatment for mild-moderate GORD in the majority of patients.
Ranitidine is available OTC, but only as 75mg tablets